Concord Biotech Limited
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Concord Biotech Limited's balance sheet done over the years? Its assets were worth $17,007,085,000 last year. 10% of Concord Biotech Limited’s total assets is currently financed by debt. Its liabilities reached the amount of $1,740,630,000.
Debt to Assets
| 2024 | 17007085000 | 1.74B | 10.23% |
|---|
CONCORDBIO.NS Balance Sheet (2023 – 2023)
| 2023 | |
|---|---|
Assets | |
Current assets: | |
Cash and cash equivalents | 151.42M |
Short term investments | 2.70B |
Net receivables | 3.49B |
Inventory | 2.07B |
Other current assets | 570.02M |
Total current assets | 8.96B |
Non-current assets: | |
Property, Plant and Equipment | 7.86B |
Goodwill | 0 |
Intangible assets | 3.19M |
Long term investments | -2.63B |
Other non-current assets | 2.81B |
Total non-current assets | 8.04B |
Total assets | 17.00B |
Liabilities | |
| Current liabilities: | |
Accounts payable | |
Deferred revenue | 36.61M |
Short term debt | 78.50M |
Total current liabilities | 1.42B |
| Non-current liabilities: | |
Long term debt | 18.87M |
Deferred tax | 0 |
Other non-current liabilities | 19.56M |
Total non-current liabilities | 319.07M |
Total liabilities | 1.74B |
| Data source |